Optimal Duration of Endocrine Therapy for Breast Cancer Optimal Duration of Endocrine Therapy for Breast Cancer
According to a new study, five years of extended adjuvant letrozole for early breast cancer was not superior to 2.5 years.Journal of the National Cancer Institute
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Health | Hematology | Study